Per ordini telefonici +39 328 5613321 / +39 0735 1983898 info@proeon.it

Puoi trovare maggiori informazioni sui principi attivi del Melateon e del Melateon PLUS consultando:

 

  • “Melatonin and sleep in aging population.” Pandi-Perumal SR, Zisapel N, Srinivasan V et al DP. Exp Gerontol 2005; 40; 911-925.
  • “Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis.” Buscemi N, Vandermeer B, Hooton N et al BMJ. 2006;332(7538):385-93.
  • “Human aging and melatonin. Clinical relevance.” Touitou Y. Exp Gerontol 2001; 36: 1083-1100.
  • “Melatonin in aging and neurodegeneration.” Savaskan E. Drug Develop Res 2002; 56: 482-490.
  • “Melatonin, human aging, and age-related diseases,” Karasek M, Experimental Gerontology vol. 39, 11-12, 2004: 1723–1729.
  • “Melatonin, aging, and age-related diseases. Perspectives for prevention, intervention and therapy.” Poeggeler B. Endocrine 2005; 27: 201-212.
  • “Physiological levels of melatonin contribute to the antioxidant capacity of human serum.” Benot S, Goberna R, Garcia-Marino S et al J Pineal Res 1999; 27: 59-64.
  • “Chemical and Physical Properties and Potential Mechanisms: Melatonin as a Broad Spectrum Antioxidant and Free Radical Scavenger,” Tan D-x, Reiter R.J., Manchester L.C. et al Curr Topics Med Chem, 2002, Vol. 2, n.2: 181-197.
  • “Inflammaging, Metabolic Syndrome and Melatonin: A Call for Treatment Studies.” Cardinali DP, Hardeland R. Neuroendocrinology. 2016 May 11.
  • “Clinical aspects of melatonin intervention in Alzheimer’s disease progression.” Cardinali DP, Furio AM, Brusco LI. Curr Neuropharmacol 2010; 8: 218-227.
  • “Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin.” Hussain SA, Khadim HM, Khalaf BH et al Saudi Med J. 2006 (10):1483-8.
  • “Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity.” Tan DX, Manchester LC, Fuentes-Broto L et al Obes Rev. 2010 Jun 16.
  • “Effects of daytime ingestion of melatonin on short-term athletic performance.” Atkinson G, Jones H, Edwards BJ et al Ergonomics. 2005; 48 (11-14):1512-22.
  • “Effects of resistance exercise session after oral ingestion of melatonin on physiological and performance responses of adult men.” Mero AA, Vähälummukka M, Hulmi JJ et al Eur J Appl Physiol. 2006 (6):729-39.
  • Masters A, Pandi-Perumal SR, Seixas A, Girardin JL, McFarlane SI., “Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment”, Brain Disorders & Therapy, 2015 Feb 19
  • Yi C, Pan X, Yan H, Guo M, Pierpaoli W., “Effects of melatonin in age-related macular degeneration”, Annals of the New York Academy of Sciences, 2005 Dec
  • Lewy AJ, Lefler BJ, Emens JS, Bauer VK., “The circadian basis of winter depression”, PNAS, 2006 May 9
  • Kandil TS, Mousa AA, El-Gendy AA, Abbas AM., “The potential therapeutic effect of melatonin in Gastro-Esophageal Reflux Disease”, BMC Gastroenterology, 2010 Jan 18
  • Kurdi MS, Muthukalai SP., “The Efficacy of Oral Melatonin in Improving Sleep in Cancer Patients with Insomnia: A Randomized Double-Blind Placebo-Controlled Study”, Indian of Journal of Palliative Care, 2016 Jul-Sep
  • Bidlingmaier M, Strasburger CJ., “Growth hormone”, Handbook of Experimental Pharmacology, 2009 Sep 17
  • Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE., “Effects of human growth hormone in men over 60 years old”, New England Journal of Medicine, 1990 Jul 5
  • Welle S, Thornton C, Statt M, McHenry B., “Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old”, The Journal of Clinical Endocrinology & Metabolism, 1996 Sep.
  • Asmaa Yehia, Osama A. Abulseoud “Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post COVID-19 trajectory of accelerated brai aging and neurodegeneration.” Molecular Neurodegeneration 19, article number: 36 (2024)
  • Li Y, Huang T, Redline S, et al. “Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies.” Lancet Diabetes Endocrinol. 2024;12(6):404-413.
     
     
     

Pin It on Pinterest